Structural characterization of the human carboxypeptidase D gene and its promoter

被引:6
作者
Timblin, B
Rehli, M
Skidgel, RA
机构
[1] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA
[2] Univ Regensburg, Dept Hematol & Oncol, D-93042 Regensburg, Germany
[3] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60612 USA
关键词
metallocarboxypeptidase; genomic structure; transcription start site; promoter;
D O I
10.1016/S1567-5769(02)00149-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human carboxypeptidase D (CPD) is a 180-kDa type I membrane protein with three tandem active site domains. CPD is a B-type (or kininase I-type) carboxypeptidase that cleaves C-terminal basic residues from proteins and peptides, such as Arg(9) from bradykinin. The human carboxypeptidase D (CPD) gene was found to encompass similar to88.3 kb of genomic sequence, containing 21 exons ranging in size from 65 to 1813 bp, and 21 introns ranging in size from 112 bp to 35.6 kb. Although CPD and CPM belong to the same metallocarboxypeptidase subfamily, their intron/exon structures differ significantly. Multiple transcription start sites were found in the CPD gene within a GC-rich sequence lacking the typical TATA box, but containing three GC boxes. Luciferase reporter assays with various size constructs containing the promoter region upstream of the start sites showed that it was active in three different cell lines, especially in the human hepatoma cell line HepG2 and the human monocytic cell line THP-1, which have high constitutive expression of CPD. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:1907 / 1917
页数:11
相关论文
共 36 条
  • [1] Carboxypeptidase I. The preparation of crystalline carboxypeptidase
    Anson, ML
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 1937, 20 (05) : 663 - 669
  • [2] IκB-NF-κB structures:: At the interface of inflammation control
    Baeuerle, PA
    [J]. CELL, 1998, 95 (06) : 729 - 731
  • [3] BHOOLA KD, 1992, PHARMACOL REV, V44, P1
  • [4] Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B)
    Boffa, MB
    Reid, TS
    Joo, E
    Nesheim, ME
    Koschinsky, ML
    [J]. BIOCHEMISTRY, 1999, 38 (20) : 6547 - 6558
  • [5] RNAs from all categories generate retrosequences that may be exapted as novel genes or regulatory elements
    Brosius, J
    [J]. GENE, 1999, 238 (01) : 115 - 134
  • [6] CHEN HM, 1993, J BIOL CHEM, V268, P8230
  • [7] Integration of cytogenetic landmarks into the draft sequence of the human genome
    Cheung, VG
    Nowak, N
    Jang, W
    Kirsch, IR
    Zhao, S
    Chen, XN
    Furey, TS
    Kim, UJ
    Kuo, WL
    Olivier, M
    Conroy, J
    Kasprzyk, A
    Massa, H
    Yonescu, R
    Sait, S
    Thoreen, C
    Snijders, A
    Lemyre, E
    Bailey, JA
    Bruzel, A
    Burrill, WD
    Clegg, SM
    Collins, S
    Dhami, P
    Friedman, C
    Han, CS
    Herrick, S
    Lee, J
    Ligon, AH
    Lowry, S
    Morley, M
    Narasimhan, S
    Osoegawa, K
    Peng, Z
    Plajzer-Frick, I
    Quade, BJ
    Scott, D
    Sirotkin, K
    Thorpe, AA
    Gray, JW
    Hudson, J
    Pinkel, D
    Ried, T
    Rowen, L
    Shen-Ong, GL
    Strausberg, RL
    Birney, E
    Callen, DF
    Cheng, JF
    Cox, DR
    [J]. NATURE, 2001, 409 (6822) : 953 - 958
  • [8] PULSE EXPOSURE TO PROTEIN-SYNTHESIS INHIBITORS ENHANCES VASCULAR-RESPONSES TO DES-ARG9-BRADYKININ - POSSIBLE ROLE OF INTERLEUKIN-1
    DEBLOIS, D
    BOUTHILLIER, J
    MARCEAU, F
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (01) : 1057 - 1066
  • [9] CONTROL OF EUKARYOTIC MESSENGER-RNA SYNTHESIS BY SEQUENCE-SPECIFIC DNA-BINDING PROTEINS
    DYNAN, WS
    TJIAN, R
    [J]. NATURE, 1985, 316 (6031) : 774 - 778
  • [10] Murine macrophage mannose receptor promoter is regulated by the transcription factors PU.1 and SP1
    Eichbaum, Q
    Heney, D
    Raveh, D
    Chung, M
    Davidson, M
    Epstein, J
    Ezekowitz, RAB
    [J]. BLOOD, 1997, 90 (10) : 4135 - 4143